Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112079781B reveals a safer synthesis route for 5-bromo-1-methyl-1H-pyrazol-3-amine, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Advanced patent CN110590606A details efficient asymmetric hydrogenation and enzymatic reduction for high-purity pharmaceutical intermediates, ensuring cost-effective and scalable supply chain solutions.
Advanced purification of Abiraterone acetate via oxalate salt formation. Eliminates column chromatography, ensures >99.5% purity, and offers scalable manufacturing solutions.
Patent CN102030798B reveals a novel triflate salt purification method for Abiraterone Acetate. Achieves >97% purity, eliminates chromatography, and ensures scalable supply.
Patent CN113512733B details an electrochemical NHK reaction for Eribulin intermediate ERB, offering greener synthesis, reduced reaction time, and improved scalability for pharmaceutical manufacturing.
Novel patent CN105601620A details high-yield mereletinib mesylate preparation ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturing partners.
Novel six-step route for epacadostat reduces complexity and enhances supply chain reliability for pharmaceutical manufacturers seeking high-purity intermediates and cost-effective production solutions.
Patent CN1900073A discloses a novel acid-catalyzed condensation for N-phenyl-2-pyrimidyl amines, offering a cost-effective and scalable route for pharmaceutical intermediates.
Technical analysis of Rhodium-catalyzed oxindole synthesis. High-purity pharmaceutical intermediates with streamlined production for cost-effective supply chain integration.
Novel cyanoacetic acid route for 2-chloro-5-cyanopyrimidine. Eliminates heavy metals and phosgene. Cost-effective industrial scale-up for API manufacturing.
Discover the novel preparation of 7-hydroxy-[1,2,4]triazolo[1,5-a]pyridine via patent CN114671867A. Achieve high purity and scalable manufacturing for HER2 inhibitors.
Novel 8-step synthesis of 5-fluoro-3-methylisobenzofuranone from phthalimide. High yield, low cost route for Laratinib intermediate suitable for commercial scale-up.
Patent CN115369430A reveals a green electrochemical route for C-3 aminomethylation. Achieves high yields without external oxidants, offering cost-effective manufacturing for pharma intermediates.
Discover advanced benzomorpholone derivatives for oncology. Our patented synthesis offers cost-effective, scalable manufacturing for high-purity BET inhibitor intermediates.
Discover the industrial production method for nitrogen-containing heterocyclic compounds with excellent FLT3 inhibitory activity. Optimized for high purity and scalable manufacturing.
Novel patent CN102010455A details a high-purity Decitabine route avoiding isomer separation. Ideal for cost reduction in API intermediate manufacturing.
Patent CN109503568A details a high-yield Dasatinib synthesis using ionic liquids and copper catalysis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN109776529B reveals a green, catalyst-free route for 1,2-diketone imidazoles, offering cost reduction and scalable manufacturing for pharma intermediates.
Novel solid-phase method for EGFR inhibitors. High purity, scalable route for anticancer drug discovery intermediates.
Discover advanced processes for preparing cyclopenta[d]pyrimidin-4-yl piperazine compounds. Enhance supply chain reliability and reduce manufacturing costs for AKT inhibitors.